USE OF PROBIOTICS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE – (01-17-05)

SYNBIOTIC THERAPY (BIFIDOBACTERIUM LONGUM/SYNERGY 1) INITIATES RESOLUTION OF INFLAMMATION IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS

While the use of probiotics to aid in the treatment of inflammatory bowel disease is not new, sometimes it’s nice just to reaffirm the efficacy and safety of this approach with a wide range of GI disorders.

Once again, we see that the long term damaging effects of antibiotic use extend well beyond the fear of antibiotic resistance.

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: